Cargando…

Steroid Pulse Therapy for De Novo Minimal Change Disease During Pregnancy

Patient: Female, 30 Final Diagnosis: Minimal change disease Symptoms: Oliguria • systemic edema Medication: — Clinical Procedure: Steroid pulse therapy Specialty: Obstetrics and Gynecology OBJECTIVE: Rare disease BACKGROUND: Nephrotic syndrome occurs very rarely, in only about 0.01–0.02% of all preg...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Hiroshi, Asami, Yuna, Shiro, Reona, Aoki, Masato, Yasuda, Miki, Imai, Saeko, Sakai, Rie, Oida, Kenji, Kawaharamura, Kanako, Yano, Hiroko, Taguchi, Nao, Suzuki, Takako, Hirose, Masaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404478/
https://www.ncbi.nlm.nih.gov/pubmed/28416778
http://dx.doi.org/10.12659/AJCR.902910
_version_ 1783231606219079680
author Sato, Hiroshi
Asami, Yuna
Shiro, Reona
Aoki, Masato
Yasuda, Miki
Imai, Saeko
Sakai, Rie
Oida, Kenji
Kawaharamura, Kanako
Yano, Hiroko
Taguchi, Nao
Suzuki, Takako
Hirose, Masaya
author_facet Sato, Hiroshi
Asami, Yuna
Shiro, Reona
Aoki, Masato
Yasuda, Miki
Imai, Saeko
Sakai, Rie
Oida, Kenji
Kawaharamura, Kanako
Yano, Hiroko
Taguchi, Nao
Suzuki, Takako
Hirose, Masaya
author_sort Sato, Hiroshi
collection PubMed
description Patient: Female, 30 Final Diagnosis: Minimal change disease Symptoms: Oliguria • systemic edema Medication: — Clinical Procedure: Steroid pulse therapy Specialty: Obstetrics and Gynecology OBJECTIVE: Rare disease BACKGROUND: Nephrotic syndrome occurs very rarely, in only about 0.01–0.02% of all pregnancies, and de novo minimal change disease during pregnancy is especially rare. Nephrotic syndrome and, especially, minimal change disease are highly responsive to steroids, and preterm labor may be avoidable if the maternal condition is improved with steroid therapy. Therefore, prompt diagnosis and proper management are critical to maternal and fetal outcome when severe proteinuria occurs during pregnancy. CASE REPORT: A 30-year-old pregnant Japanese woman presented with systemic edema, oliguria, and severe proteinuria and hypoalbuminemia at 25 weeks of gestation, although she was normotensive. The patient had high urinary protein selectivity. Her illness was diagnosed as de novo nephrotic syndrome with high steroid responsiveness rather than pre-eclampsia. She began steroid pulse therapy the day after admission. Complete remission was confirmed after 3 weeks. The patient did not relapse during pregnancy and delivered a healthy male baby at 37 weeks of gestation. A renal biopsy at a relapse after delivery confirmed minimal change disease. CONCLUSIONS: In pregnant women with de novo minimal change disease, serious maternal and/or fetal complications may occur if severe proteinuria and hypoalbuminemia are unabated for an extended time. Evaluation of urinary protein selectivity is noninvasive and useful for prediction of steroid responsiveness. Results of urinary protein selectivity can be obtained earlier than results of renal biopsy. Renal biopsy during pregnancy is not always necessary for initiation of steroid therapy. Rapid initiation of steroid pulse therapy may enable quicker achievement of remission and prevent serious perinatal complications.
format Online
Article
Text
id pubmed-5404478
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-54044782017-05-03 Steroid Pulse Therapy for De Novo Minimal Change Disease During Pregnancy Sato, Hiroshi Asami, Yuna Shiro, Reona Aoki, Masato Yasuda, Miki Imai, Saeko Sakai, Rie Oida, Kenji Kawaharamura, Kanako Yano, Hiroko Taguchi, Nao Suzuki, Takako Hirose, Masaya Am J Case Rep Articles Patient: Female, 30 Final Diagnosis: Minimal change disease Symptoms: Oliguria • systemic edema Medication: — Clinical Procedure: Steroid pulse therapy Specialty: Obstetrics and Gynecology OBJECTIVE: Rare disease BACKGROUND: Nephrotic syndrome occurs very rarely, in only about 0.01–0.02% of all pregnancies, and de novo minimal change disease during pregnancy is especially rare. Nephrotic syndrome and, especially, minimal change disease are highly responsive to steroids, and preterm labor may be avoidable if the maternal condition is improved with steroid therapy. Therefore, prompt diagnosis and proper management are critical to maternal and fetal outcome when severe proteinuria occurs during pregnancy. CASE REPORT: A 30-year-old pregnant Japanese woman presented with systemic edema, oliguria, and severe proteinuria and hypoalbuminemia at 25 weeks of gestation, although she was normotensive. The patient had high urinary protein selectivity. Her illness was diagnosed as de novo nephrotic syndrome with high steroid responsiveness rather than pre-eclampsia. She began steroid pulse therapy the day after admission. Complete remission was confirmed after 3 weeks. The patient did not relapse during pregnancy and delivered a healthy male baby at 37 weeks of gestation. A renal biopsy at a relapse after delivery confirmed minimal change disease. CONCLUSIONS: In pregnant women with de novo minimal change disease, serious maternal and/or fetal complications may occur if severe proteinuria and hypoalbuminemia are unabated for an extended time. Evaluation of urinary protein selectivity is noninvasive and useful for prediction of steroid responsiveness. Results of urinary protein selectivity can be obtained earlier than results of renal biopsy. Renal biopsy during pregnancy is not always necessary for initiation of steroid therapy. Rapid initiation of steroid pulse therapy may enable quicker achievement of remission and prevent serious perinatal complications. International Scientific Literature, Inc. 2017-04-18 /pmc/articles/PMC5404478/ /pubmed/28416778 http://dx.doi.org/10.12659/AJCR.902910 Text en © Am J Case Rep, 2017 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Articles
Sato, Hiroshi
Asami, Yuna
Shiro, Reona
Aoki, Masato
Yasuda, Miki
Imai, Saeko
Sakai, Rie
Oida, Kenji
Kawaharamura, Kanako
Yano, Hiroko
Taguchi, Nao
Suzuki, Takako
Hirose, Masaya
Steroid Pulse Therapy for De Novo Minimal Change Disease During Pregnancy
title Steroid Pulse Therapy for De Novo Minimal Change Disease During Pregnancy
title_full Steroid Pulse Therapy for De Novo Minimal Change Disease During Pregnancy
title_fullStr Steroid Pulse Therapy for De Novo Minimal Change Disease During Pregnancy
title_full_unstemmed Steroid Pulse Therapy for De Novo Minimal Change Disease During Pregnancy
title_short Steroid Pulse Therapy for De Novo Minimal Change Disease During Pregnancy
title_sort steroid pulse therapy for de novo minimal change disease during pregnancy
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404478/
https://www.ncbi.nlm.nih.gov/pubmed/28416778
http://dx.doi.org/10.12659/AJCR.902910
work_keys_str_mv AT satohiroshi steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy
AT asamiyuna steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy
AT shiroreona steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy
AT aokimasato steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy
AT yasudamiki steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy
AT imaisaeko steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy
AT sakairie steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy
AT oidakenji steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy
AT kawaharamurakanako steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy
AT yanohiroko steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy
AT taguchinao steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy
AT suzukitakako steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy
AT hirosemasaya steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy